Oh, the perils of working at a high-tech startup company. Tamara Tompkins, until this week the general counsel of the biotech firm Amyris Inc., found out the hard way.
After its stock tanked, Amyris said Wednesday in a filing with the Securities and Exchange Commission that it was replacing several members of its top management including Tompkins. It had already replaced its chief financial officer.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
